Please login to the form below

Not currently logged in
Email:
Password:

Agios Pharma

This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a specific genetic mutation. ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Chris Bowden joins Agios Chris Bowden joins Agios

    Chris Bowden joins Agios. He is former VP, product development oncology at Genentech. ... Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics